Trevena, Inc. Names Arthur Fratamico Chief Business Officer
KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Trevena, Inc., the leader in G-protein coupled receptor (GPCR) biased ligand drug discovery, today announced the appointment of Arthur Fratamico, R.Ph., MBA, to the position of chief business officer. In this role, Mr. Fratamico is responsible for Trevena’s business and strategic development.